惠颖,朱津津,杨星钢,刘丹丹,聂淑芳,潘卫三
HUI Ying,ZHU Jin-jin,YANG Xing-gang,LIU Dan-dan,NIE Shu-fang,PAN Wei-san(School of Pharmacy

• 1:沈阳药科大学药学院

摘要(Abstract)：

目的制备多单元胃漂浮制剂双嘧达莫胃漂浮缓释微丸,并考察其体外漂浮和释放性质。方法采用挤出滚圆法制备轻质含药丸芯,底喷流化床包衣技术将乙基纤维素(EC)喷于含药丸芯表面形成缓释膜材,控制微丸的漂浮性和药物的释放特性;采用正交试验设计对包衣微丸的处方进行优化和筛选,并对最佳处方进行验证试验及释放模型拟合。结果包衣液中致孔剂含量质量分数为20%、增塑剂含量质量分数为5%、包衣质量分数增加为4%时,所得微丸的体外漂浮性和缓释释放度均达到了要求。12 h微丸的漂浮率大于90%,8 h累计释放量达到85%以上,包衣微丸的释药符合一级释药模型。结论自制产品质量稳定,工艺简单可靠,所得的胃漂浮缓释微丸达到了缓释与漂浮的双重要求。
Objective To study the preparation of multiple-unit formulation-DIP gastric-floating sustained-release micro-pills and its evaluation in vitro. Methods The extrusion-rolling method was taken to prepare light-weight pill cores and bottom-spraying technology of fluid bed was performed to spray EC on the surface of pill cores to form sustained-release membrane to control the floatability of micro-pills and its drug release.Orthogonal designed test was used to optimize and select formulation of coated micro-pellets,then the reproducibility of the optimal formulation was tested and the release model was fitted. Results When coated micro-pills were prepared under the optimal prescription,its floating ability and release characters both reached the requirements:drug release rate was over 85% after 8 h,micro-pills floating percent was over 90% after 12 h and its release properties fit to first-order model. Conclusions The preparation method of the micro-pills is feasible and reliable.The products reach the requirements of floatability and sustained-release at the same time.

关键词(KeyWords)： 双嘧达莫;胃漂浮;缓释微丸;挤出滚圆法;流化包衣法;体外漂浮性;体外释放度
dipyridamole;gastric-floating;sustained-release micro-pill;extrusion-rolling method;fluid-bed coating method;floatability in vitro;release in vitro

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 惠颖,朱津津,杨星钢,刘丹丹,聂淑芳,潘卫三
HUI Ying,ZHU Jin-jin,YANG Xing-gang,LIU Dan-dan,NIE Shu-fang,PAN Wei-san(School of Pharmacy

DOI: 10.14066/j.cnki.cn21-1349/r.2011.02.013

参考文献(References)：

• [1]袁志敏,武云霞.双嘧达莫治疗心血管疾病研究进展[J].国外医学:老年医学分册,2002,23(1):6-9.
• [2]张安阳,范田园.多单元胃漂浮给药系统研究进展[J].国际药学研究,2007,34(4):274-279.
• [3]MAHONY C,WOLF RAM K M,COCCHETTO D M,etal.Dipyridamole kinetics in man[J].Clin PharmacolTherap,1982,31:330-333.
• [4]ARAFAT T,SAKET M,AWAD R,et al.A bioequiva-lence study of two dipyridamole products[J].Int J Clinpharmacol Ter Toxicol,1989,27:564-566.
• [5]张军,邓树海.双嘧达莫阿司匹林胃内漂浮片的研究[J].中国医药工业杂志,2005,36(11):682-684.
• [6]孔少仪,林染,陈刚梅.双嘧达莫胃内漂浮片的研制[J].中国医药工业杂志,2003,34(8):395-396.
• [7]张志宏,唐歆,彭博,等.星点设计-效应面法优化双嘧达莫漂浮渗透泵给药系统[J].药学学报,2009,44(2):203-207.
• [8]国家药典委员会.中华人民共和国药典:二部[M].北京:化学工业出版社,2005:附录75.
• [9]KORSMEYER R W,GURNY R,DOELKER E.Mecha-nism of solute release from porous hydrophilic polymers[J].Int J Pharm,1983,15:25-35.
• [10]SCHWARTZ J B,SIMONELLI AP,HIGUCHI W.Drugrelease from wax matrics I.Analysis of data with first-order kinetics and with diffusion-cont rolled model[J].J Pharm Sci,1968,57(2):274-277.
• [11]HIGUCHI T.Mechanism of sustained-action medica-tion.Theoretical analysis of rate of release of soliddrugs dispersed in solid matrices[J].J Pharm Sci,1963,52(12):1145-1149.